Veterinary Medicines

Benazecare Flavour 5 mg Tablets for Dogs and Cats

Authorised
This information is not available for this product.
Download as PDF

Product identification

Medicine name:
Benazecare Flavour 5 mg Tablets for Dogs and Cats
Active substance:
This information is not available for this product.
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 14 tablets.
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 28 tablets.
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 56 tablets.
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 140 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Animalcare Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • VM 10347/4022
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0452/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Netherlands
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."